These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27439258)

  • 1. [Phosphate binders].
    Heeb RM
    Med Monatsschr Pharm; 2016 Jun; 39(6):255-60. PubMed ID: 27439258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
    Negri AL
    J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphate binders : What are the recent evidences ?].
    Bouajila IA; Martin PY; De Seigneux S
    Rev Med Suisse; 2017 Feb; 13(551):468-472. PubMed ID: 28714648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles.
    Locatelli F; Del Vecchio L; Violo L; Pontoriero G
    Expert Opin Drug Saf; 2014 May; 13(5):551-61. PubMed ID: 24702470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperphosphatemia in Dialysis Patients: Beyond Nonadherence to Diet and Binders.
    Sherman RA
    Am J Kidney Dis; 2016 Feb; 67(2):182-6. PubMed ID: 26508681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to phosphate binders in hemodialysis patients: prevalence and determinants.
    Van Camp YP; Vrijens B; Abraham I; Van Rompaey B; Elseviers MM
    J Nephrol; 2014 Dec; 27(6):673-9. PubMed ID: 24563270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.
    Galassi A; Cupisti A; Santoro A; Cozzolino M
    J Nephrol; 2015 Aug; 28(4):415-29. PubMed ID: 25245472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of phosphate binders in chronic kidney disease.
    Ketteler M; Biggar PH
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):413-20. PubMed ID: 23736841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperphosphatemia in dialysis: which binder?].
    Alfieri C; Malberti F; Mazzaferro S; Gallieni M; Russo D; Messa P; Cozzolino M
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease.
    Ahlenstiel T; Pape L; Ehrich JH; Kuhlmann MK
    Nephrol Dial Transplant; 2010 Oct; 25(10):3241-9. PubMed ID: 20308040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate: a stealthier killer than previously thought?
    Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
    Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis.
    Zhai CJ; Yu XS; Yang XW; Sun J; Wang R
    Ren Fail; 2015 Feb; 37(1):7-15. PubMed ID: 25350834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study.
    Leung S; McCormick B; Wagner J; Biyani M; Lavoie S; Imtiaz R; Zimmerman D
    BMC Nephrol; 2015 Dec; 16():205. PubMed ID: 26645271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newly development of phosphate binders in hyperphosphatemic patients with kidney dysfunction].
    Negi S; Yamanaka S; Koreeda D; Yashiro M; Shigematsu T
    Clin Calcium; 2012 Oct; 22(10):1557-66. PubMed ID: 23023637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphate binders usage, patients knowledge, and adherence. A cross-sectional study in 4 centers at Qassim, Saudi Arabia.
    Aleidi AM; Alayed NJ; Alduraibi HM; Alqassimi NS; Ismail AA
    Saudi Med J; 2020 Oct; 41(10):1076-1082. PubMed ID: 33026048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily dietary phosphorus intake variability and hemodialysis patient adherence to phosphate binder therapy.
    Tao X; Zhang H; Yang Y; Zhang C; Wang M
    Hemodial Int; 2019 Oct; 23(4):458-465. PubMed ID: 31328873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of hyperphosphatemia in dialysis patients: the role of phosphate binders].
    Malberti F
    G Ital Nefrol; 2010; 27 Suppl 52():S47-54. PubMed ID: 21132662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?
    Cozzolino M; Mazzaferro S; Brandenburg V
    Nephrol Dial Transplant; 2011 Feb; 26(2):402-7. PubMed ID: 21079194
    [No Abstract]   [Full Text] [Related]  

  • 20. Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.
    Savica V; Calò LA; Monardo P; Davis PA; Granata A; Santoro D; Savica R; Musolino R; Comelli MC; Bellinghieri G
    J Am Soc Nephrol; 2009 Mar; 20(3):639-44. PubMed ID: 19020004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.